The last thing a company wants to do is understate their profits to Congress by 60%. That’s what Mylan did, the company which makes the EpiPen. According to The Wall Street Journal, Mylan is now admitting that it understated the profits it derives from the EpiPen, a life-saving allergy drug, by 60% in a congressional … Continue reading “Mylan (MYL) Lied About Its EpiPen Profits To Congress”
